Robo.ai announces proposed acquisition of QC Capital, an AI-Driven technology holding and venture-building platform
Read More 1 minute read Health Accutar Biotechnology Receives NMPA Clearance of IND Application for AC0682 in ER-Positive Breast Cancer BROOKLYN, N.Y. & SHANGHAI – Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered… byKarrenApril 4, 2022